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A crucial nephron segment 
in acid–base and electrolyte 
transport: The connecting tubule
G Capasso1
The cortical distal nephron is a heterogenous structure where the fine 
regulation of electrolyte and water balance takes place. Among the 
other segments, previous reports have emphasized the importance 
of the connecting tubule in sodium and potassium renal handling. 
Kovacikova et al. report that the connecting tubule is also the major 
segment in electrogenic urinary acidification, thus reinforcing the 
central role of this segment in overall  electrolyte transport.
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Th e cortical distal nephron is the segment 
devoted to the fi ne regulation of electrolyte 
and water balance. Th e increasing impor-
tance of this nephron portion is underlined 
by the fi ndings that human disorders of 
electrolyte balance are linked to mutations 
of genes encoding salt and water transport 
proteins expressed in the distal nephron.
Following histological criteria, the distal 
nephron includes a straight portion (the 
thick ascending limb (TAL)) and the distal 
convolution. According to structural and 
functional factors, the latter is composed 
of the distal convoluted tubule (DCT) and 
the connecting tubule (CNT). On the basis 
of functional studies, the cortical collect-
ing duct (CCD) is incorporated into the 
distal nephron.1
Th e issue is further complicated by spe-
cies differences. In all animals studied, 
downstream of the macula densa, the TAL 
epithelium changes abruptly to the DCT. 
In rabbits the DCT is composed of one cell 
type, very enriched with mitochondria. 
Th e DCT cells are abruptly replaced by the 
CNT cells, which have fewer mitochondria 
than do DCT cells. Intercalated cells do not 
appear before the transition to the CNT; 
the CCD starts abruptly with the substitu-
tion of CNT by CCD cells (principal cells). 
On the contrary, the distal convolution of 
a superfi cial rat nephron is made by a total 
of four cell types (DCT, CNT, principal, 
and intercalated cells) that progressively 
replace each other and sometimes become 
intermingled. Th erefore, in the rat, there is 
a gradual segmental transition. Th e same 
holds for the distal convolutions of mice 
and humans.2
Functional and immunohistochemical 
studies have shown that the distal neph-
ron expresses, in a sequential arrange-
ment, the following transport proteins: 
the bumetanide-sensitive sodium-2 chlo-
ride potassium cotransporter (NKCC2), 
the thiazide-sensitive sodium-chloride 
cotransporter (NCC), the amiloride-
sensitive epithelial sodium channel (ENaC), 
and the vasopressin-sensitive water channel 
aquaporin-2 (AQP2). In addition, because 
this segment is an important site for active 
calcium reabsorption, there is abundant 
expression of the epithelial calcium chan-
nel (TRPV5), the basolateral sodium/cal-
cium exchanger (NCX), and the plasma 
membrane Ca2+-ATPase (PMCA), as well 
as the cytoplasmic calcium-binding protein 
calbindin D28k.
With respect to the longitudinal dis-
tribution, NKCC2 is restricted to the 
TAL, including the macula densa, and 
diff erentiates this segment from all others, 
in all species. NCC replaces NKCC2 exactly 
at the structural transition from the TAL to 
the DCT. Th ere are species diff erences in 
the site of the beginning of ENaC, TRPV5, 
and AQP2 expression, along the distal con-
volution. In the rabbit kidney, ENaC follows 
NCC, and it is replaced abruptly by TRPV5. 
Th e vasopressin-sensitive water channel 
AQP2 sharply marks the beginning of the 
CCD, which structurally is discernible by 
the abrupt appearance of the principal cells. 
Th e basolateral NCX is found exclusively in 
the CNT, whereas calbindin D28k appears 
in the DCT, rises sharply with the beginning 
of the CNT, and continues somewhat more 
weakly along the CCD. Although in the rab-
bit the pattern of distribution of the various 
transporters is precise, in the rat there is a 
more gradual transition. In the late portion 
of the DCT, cells show, in addition to NCC, 
the apical channels ENaC and TRPV5. 
Furthermore, they display a very high abun-
dance of cytoplasmic calbindin D28k and 
basolateral NCX, and AQP2 staining starts 
with the ending of NCC staining or may be 
intermingled even with the last few NCC-
positive cells. In mice, and most probably 
in humans, the distribution of NCC, ENaC, 
TRPV5, and AQP2 resembles that in rats3 
(Figure 1).
Th e tubular distribution of the transport 
proteins helps us to understand the com-
plex distal nephron organization in the 
mammalian species. In all four species so 
far studied, NKCC2 is the most upstream 
apical salt transporter and unambigu-
ously identifi es the TAL. Th e succeeding 
salt transporter is the NCC that marks 
the onset and end of the DCT. Th e subse-
quently apical ion transporters are ENaC 
and TRPV5. In rabbits they abruptly 
replace NCC in the apical membrane. 
In rats, mice, and humans, ENaC and 
TRPV5 seem to appear earlier along the 
DCT, marking a subsegment with apical 
coexpression of NCC, ENaC, and TRPV5. 
Th erefore, in these species the DCT may 
additionally be subdivided into an early 
and a late portion.4 Th is last subsegment 
is also characterized by the appearance of 
intercalated cells and by the expression of 
cytoplasmic calbindin D28k, basolateral 
NCX, and PMCA.
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Th e disappearance of NCC marks, in 
all species, the beginning of the CNT. In 
rabbits, it coincides with the expression of 
ENaC, TRPV5, and basolateral NCX; in 
rats and mice, it coincides with more AQP2 
immunostaining. Th e presence of AQP2, 
in a tubule located in the medullary ray, 
identifi es the CCD.
Th e presence of various ion transport-
ers, sequentially distributed along the dis-
tal nephron, guarantees complete sodium 
recovery under a large range of physio-
pathological conditions, including impair-
ment of sodium reabsorption in the TAL, 
for instance by the use of loop diuretics or 
by genetic defects.2
Th e complexity and the heterogeneity 
of the distal nephron raise some questions 
about the role of each tubular segment. So 
far, several studies have emphasized the 
role of the collecting duct, which is con-
sidered as the site where the fi nal control of 
urinary electrolytes takes place.5 However, 
recent fi ndings suggest that the CNT (and, 
in the rat, the mouse, and the human, also 
the late DCT) is the main segment where 
urinary sodium and potassium excretion is 
fi nely regulated, and that the collecting duct 
gets involved when the upstream segments 
become overloaded. As recently summa-
rized in an excellent review,6 the evidence 
of this hypothesis is based on the follow-
ing fi ndings: (1) the same ion transporters 
and their regulatory proteins, present in the 
principal and intercalated cells that make 
the collecting duct, are localized in the 
CNT; (2) apical accumulation of ENaC and 
K channels induced by dietary manipula-
tion starts in the CNT; (3) the lack of ENaC 
in the collecting duct does not weaken the 
adaptation of mice to low sodium intake; 
(4) the CNT has a very large sodium and 
potassium transepithelial transport capa-
bility as compared with the collecting duct; 
(5) several regulatory proteins linked to 
hypertensive states are localized in the CNT 
rather than in the collecting duct; and (6) 
the high sodium and low potassium intakes 
typical of Western diet are handled almost 
entirely by the CNT, with little involvement 
of the collecting duct. Th erefore, most of 
the data collected recently suggest that 
sodium reabsorption and potassium secre-
tion in the CNT are suffi  cient to maintain 
sodium and potassium balance, with little 
or no contribution of the collecting duct.6
Kovacikova et al.7 (this issue) extend 
the pivotal role of the CNT in electrolyte 
transport to acid–base balance. In this 
segment two main transport proteins 
regulate acid–base handling: the vacuolar 
H+-ATPase and the Cl–/HCO3
– exchanger 
AE-1, both expressed in the acid–base-
transporting cells, that is, the intercalated 
cells.8 Vacuolar H+-ATPases mediate 
ATP-driven vectorial transport of protons 
across membranes. Th ey are composed 
of at least 13 subunits: the B1 isoform 
(ATP6V1B1) is expressed in specialized 
cells including all subtypes of intercalated 
cells of the kidney. Generally, two types 
of intercalated cells are identifi ed: type A 
intercalated cells are responsible for the 
net excretion of protons through apical 
localized vacuolar H+-ATPases. Th e gen-
erated HCO3
– is released into the blood 
by the basolateral kidney-specific iso-
form of the Cl–/HCO3
– exchanger band 
3/AE-1 (SLC4A1). In contrast, during 
metabolic alkalosis, type B intercalated 
cells are activated. These cells secrete 
bicarbonate into the urine via an apically 
located Cl–/HCO3
– exchanger (pendrin 
or AE-4), whereas basolaterally expressed 
vacuolar H+-ATPases extrude protons 
into the interstitium. Th e CNT is rich in 
intercalated cells, with a greater percent-
age of B cells and more of the subclass of 
intercalated cells that have apical vacuolar 
H+-ATPases but no basolateral AE-1.9
Kovacikova et al.7 investigated the func-
tional interaction between renal Na+ reab-
sorption, through ENaC, and H+ secretion 
by vacuolar H+-ATPases in the CNT and 
CCD. H+ secretion by vacuolar H+-ATPases 
is electrogenic and thought to be indirectly 
coupled to Na+ reabsorption. According to 
this hypothesis, Na+ reabsorption through 
ENaC creates a more lumen-negative 
transtubular voltage, which in turn would 
enhance H+ secretion by vacuolar H+-
ATPases. Th us, the furosemide-induced 
increase in Na+ delivery to the CNT and 
CCD will enhance the reabsorption of this 
delivered fraction through ENaC, stimu-
lating urinary acidifi cation mediated by 
vacuolar H+-ATPases. In particular, the 
B1 isoform seems to be implicated, as only 
a mild acidifi cation could be observed in 
Atp6v1b1-defi cient mice (which lack the 
B1 isoform, ATP6V1B1).7
In another set of experiments, the 
consequence of the genetic ablation of 
ENaC channel function was tested in 
Scnn1aloxloxCre mice.7 These animals 
have no detectable ENaC channel func-
tion in the CCD and outer medullary col-






































Figure 1 | Schematic overview of the different cell types lining the distal tubule and the 
connecting segment. At least four cell types are present along these segments. In rats, in mice, 
and most probably in humans, there is a gradual transition from one to another cell type; the same 
holds for the various transporters. D28k, calbindin D28k; ICC, intercalated cell (other abbreviations 
are as defined in the text).
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function and localization have remained 
normal. In the control and ENaC-defi cient 
mice, furosemide induced normal urinary 
acidifi cation with a similar increase in frac-
tional electrolyte excretion.7 Th erefore it 
appears that the residual ENaC function in 
the CNT may be adequate for the furosem-
ide-dependent urinary acidifi cation. Th ese 
data demonstrate that the CNT is the major 
segment in electrogenic urinary acidifi ca-
tion, thus reinforcing the central role of the 
CNT in overall electrolyte transport.
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Focal segmental 
glomerulosclerosis: Cellular variant 
and beyond
R Nair1
The entity of focal segmental glomerulosclerosis (FSGS), oddly, includes 
several distinct changes involving glomeruli that need not be focal, 
segmental, or even sclerotic. It is fitting to rethink our nosological 
approach to FSGS, which has focused on descriptive morphological 
entities. Rather, we should consider them as ‘podocytopathies’ — diseases 
with an etiological commonality involving injury to the podocyte.
Kidney International (2006) 70, 1676–1678. doi:10.1038/sj.ki.5001944
Primary focal segmental glomerulosclero-
sis (FSGS) represents a group of diseases 
that present with nephrotic syndrome or 
nephrotic-range proteinuria and are char-
acterized by varied glomerular morpho-
logical changes. 
Th e fi ve variants of FSGS as proposed 
in the Columbia Classifi cation of 2004 are 
listed in Table 1. Several causes of FSGS, 
both genetic and acquired, have been 
reported in the past decade,1 and new 
ones are being discovered. Even though 
the glomerular lesions of FSGS may not 
be focal, segmental, or sclerotic, they have 
a common anatomic injury involving the 
glomerular epithelial cell, oft en referred to 
as podocytopathy. Variants of FSGS such 
as cellular (CELL), collapsing (COLL), and 
glomerular tip lesion (GTL) have been his-
torically designated as FSGS, as they oft en 
have coexisting segmental sclerotic lesions 
of the classic (not otherwise specified 
(NOS)) type and have nephrotic-range 
proteinuria. However, collective inclusion 
under the banner of FSGS may not be as 
appropriate as it may seem. For example, 
GTL may be more appropriately consid-
ered a form of minimal-change disease 
rather than of FSGS, given the excellent 
response to treatment in many instances.2 
To quote Martin Pollack, “Too oft en, we 
talk about histologic patterns of injury, 
such as focal and segmental glomerulo-
sclerosis, as if they were diseases rather 
than descriptions of kidney biopsy speci-
mens at particular points in time.”3 An 
alternative approach to understanding and 
classifying the variants of primary FSGS 
is to consider them as ‘podocytopathies’ 
(Table 1). Such a categorization might well 
also include minimal-change disease4 but 
exclude the perihilar FSGS variant, for 
reasons discussed shortly. Th is may be a 
more elegant approach that would refer to 
a disease process rather than a nonspecifi c 
pathological fi nding.
It has to be emphasized that segmen-
tal sclerotic lesions can simply represent 
glomerular scars and can be seen in a 
myriad of conditions, such as chronic cres-
centic glomerulonephritis and chronic IgA 
nephropathy, Alport’s syndrome, Fabry’s 
disease, and so on — the so-called ‘fi nal 
common pathway’. In this sense, FSGS can 
be considered as a fi nal histopathological 
end point to varying biological mecha-
nisms.5 Every eff ort should be made to rule 
out a secondary (non-podocytopathic) 
cause for FSGS. Th is can prove to be quite 
diffi  cult when the sequential clinical events 
over the period of time the patient was fol-
lowed are not known. Th e clinician should 
beware the purely pathological diagnosis 
of FSGS — not otherwise specifi ed. Th e 
term ‘FSGS’ can be misleading and per-
haps should be used only as a descriptive 
morphological term.
It is in this context that a concerted 
attempt to defi ne the various glomeru-
lar lesions that fall under the collective 
umbrella of the term ‘FSGS’ was made by a 
group of leading renal pathologists in what 
is popularly referred to as the Columbia 
Classifi cation.6 Although there are some 
1Department of Pathology, University of Iowa, 
Iowa City, Iowa, USA
Correspondence: R Nair, Department of 
Pathology, University of Iowa, 200 Hawkins Drive, 
RCP 5243, Iowa City, Iowa 52242, USA.
 E-mail: ramesh-nair@uiowa.edu
